Approval · Notice of Compliance 4513 · 1996
APO-LOPERAMIDE: Notice of Compliance 4513
Issued February 26, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4513
- Date
- February 26, 1996
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Oral antidiarrheal agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-LOPERAMIDE | 02212005 | Dormant |
Medicinal ingredients
- LOPERAMIDE HCL 2 MG per TAB